Literature DB >> 11527376

The effects of AICAR on adipocyte differentiation of 3T3-L1 cells.

S A Habinowski1, L A Witters.   

Abstract

The AMP-activated protein kinase (AMPK) activator, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), has been found to inhibit the differentiation of 3T3-L1 adipocytes, if added at an early phase of differentiation. AICAR blocks the expression of the late adipogenic markers, fatty acid synthase and acetyl-CoA carboxylase, and of the transcription factors, C/EBPalpha and PPARgamma. It also inhibits early clonal expansion of pre-adipocytes, prevents the fall in C/EBPbeta expression during the intermediate stage of differentiation and inhibits the late phase expression of CHOP-10, an antagonist of C/EBPbeta. These data suggest a possible inhibitory role for AMPK in the process of adipose differentiation and suggest that AMPK might be a target to block adipogenesis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527376     DOI: 10.1006/bbrc.2001.5484

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  79 in total

Review 1.  The blooming of the French lilac.

Authors:  L A Witters
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 2.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

3.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

4.  Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway.

Authors:  Katarzyna A Cieslik; Joann Trial; Mark L Entman
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

5.  Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity.

Authors:  Mandeep P Gaidhu; Andrea Frontini; Steven Hung; Kathryn Pistor; Saverio Cinti; Rolando B Ceddia
Journal:  J Lipid Res       Date:  2011-07-07       Impact factor: 5.922

6.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Authors:  Yan Shu; Steven A Sheardown; Chaline Brown; Ryan P Owen; Shuzhong Zhang; Richard A Castro; Alexandra G Ianculescu; Lin Yue; Joan C Lo; Esteban G Burchard; Claire M Brett; Kathleen M Giacomini
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  Maternal obesity, inflammation, and fetal skeletal muscle development.

Authors:  Min Du; Xu Yan; Jun F Tong; Junxing Zhao; Mei J Zhu
Journal:  Biol Reprod       Date:  2009-06-10       Impact factor: 4.285

8.  Synergistic effects of caffeine and catechins on lipid metabolism in chronically fed mice via the AMP-activated protein kinase signaling pathway.

Authors:  Yan Zhao; Licong Yang; Zhanwang Huang; Lezhen Lin; Guodong Zheng
Journal:  Eur J Nutr       Date:  2016-07-21       Impact factor: 5.614

9.  Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.

Authors:  Myriam Bronner; Rachel Hertz; Jacob Bar-Tana
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

10.  Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance.

Authors:  Chi Bun Chan; Xia Liu; Dae Young Jung; John Y Jun; Hongbo R Luo; Jason K Kim; Keqiang Ye
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.